What is the ICD‑10‑CM code for left‑sided hormone‑receptor‑positive breast cancer?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

ICD-10-CM Code for Left-Sided Hormone Receptor-Positive Breast Cancer

The ICD-10-CM code for left-sided hormone receptor-positive breast cancer is C50.912 (Malignant neoplasm of unspecified site of left female breast) or a more specific code from the C50.x11-C50.x12 series if the exact quadrant or location within the left breast is known.

Code Structure and Selection

The ICD-10-CM coding system for breast cancer follows this pattern:

  • C50.xxx = Malignant neoplasm of breast
  • The fourth character specifies the anatomic location (e.g., 0 = nipple, 1 = central portion, 2 = upper-inner quadrant, 3 = lower-inner quadrant, 4 = upper-outer quadrant, 5 = lower-outer quadrant, 8 = overlapping sites, 9 = unspecified)
  • The fifth character indicates laterality:
    • 1 = right breast
    • 2 = left breast
    • 9 = unspecified side

Specific Left Breast Codes:

  • C50.011 = Malignant neoplasm of nipple and areola, left female breast
  • C50.112 = Malignant neoplasm of central portion of left female breast
  • C50.212 = Malignant neoplasm of upper-inner quadrant of left female breast
  • C50.312 = Malignant neoplasm of lower-inner quadrant of left female breast
  • C50.412 = Malignant neoplasm of upper-outer quadrant of left female breast
  • C50.512 = Malignant neoplasm of lower-outer quadrant of left female breast
  • C50.812 = Malignant neoplasm of overlapping sites of left female breast
  • C50.912 = Malignant neoplasm of unspecified site of left female breast

Important Coding Considerations

The ICD-10-CM code does NOT capture hormone receptor status directly. The code identifies the anatomic location and laterality of the breast cancer only. Hormone receptor-positive status (ER+, PR+, or both) is documented separately in the medical record through pathology reports and immunohistochemistry results 1.

Key Points:

  • Laterality is built into ICD-10-CM codes 2, which is an improvement over ICD-9-CM
  • Use the most specific anatomic code available based on imaging and pathology documentation
  • If the exact quadrant is unknown, use C50.912 for left breast, unspecified site
  • Hormone receptor status should be documented separately in clinical notes and pathology reports, not through the ICD-10 code itself

Clinical Documentation Requirements:

For accurate coding, ensure documentation includes:

  • Laterality (left breast)
  • Specific anatomic location within the breast (quadrant, nipple, central)
  • Hormone receptor status (ER and PR expression levels) in pathology reports 1
  • HER2 status for complete characterization

The hormone receptor-positive designation is critical for treatment planning 1, 3 but is captured through clinical documentation and pathology coding systems, not the primary ICD-10-CM diagnosis code.

References

Related Questions

What is the ICD-10 code for invasive hormone receptor‑positive breast cancer?
What is the ICD‑10‑CM code for left‑sided multicentric breast cancer?
What is the appropriate ICD-10 code for hormone-receptor-positive breast cancer?
What is the ICD‑10‑CM code for a right‑sided hormone‑receptor‑positive, HER2‑negative breast cancer?
What does ICD‑10‑CM code F90.8 represent?
For a patient taking trazodone 150 mg at bedtime, hydroxyzine 25 mg every 6 hours as needed, isosorbide, memantine, metformin, a statin, nitroglycerin, midodrine, entacapone, glucosamine, hyoscyamine, carbidopa‑levodopa, quetiapine 50 mg three times daily with an additional 50 mg PRN, escitalopram, melatonin 3 mg at bedtime, Miralax, vitamin D, and senna, who is experiencing behavioral disturbances and insomnia, what medication adjustments should be recommended?
What is the renal protection protocol for an adult patient with chronic kidney disease undergoing a left heart catheterization?
What is the recommended dosing of Robitussin DM (dextromethorphan and guaifenesin) for children of various ages and for adults?
What is the appropriate management for a geriatric patient experiencing functional decline?
Which oral antipsychotic medications are appropriate for treating acute psychosis?
In a patient with endometriosis and mast cell activation syndrome who is currently taking the progestin‑only pill drospirenone 4 mg (Slynd) and not on combined hormonal therapy, should oral micronized progesterone be added or substituted, and what are the recommended next steps for pain management?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.